Mou J - Search Results

1

Design, synthesis and preliminary activity evaluation of novel L-lysine derivatives as aminopeptidase N/CD13 inhibitors.

Wang Q, Xu F, Mou J, Zhang J, Shang L, Luan Y, Yuan Y, Liu Y, Li M, Fang H, Wang B, Xu W. Wang Q, et al. Among authors: mou j. Protein Pept Lett. 2010 Jul;17(7):847-53. doi: 10.2174/092986610791306661. Protein Pept Lett. 2010. PMID: 20156182

2

Design, synthesis, and primary activity evaluation of pyrrolidine derivatives as matrix metalloproteinase inhibitors.

Zhang J, Li X, Zhu HW, Wang Q, Feng JH, Mou JJ, Li YG, Fang H, Xu WF. Zhang J, et al. Among authors: mou jj. Drug Discov Ther. 2010 Feb;4(1):5-12. Drug Discov Ther. 2010. PMID: 22491146 Free article.

3

Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.

Mou J, Fang H, Jing F, Wang Q, Liu Y, Zhu H, Shang L, Wang X, Xu W. Mou J, et al. Bioorg Med Chem. 2009 Jul 1;17(13):4666-73. doi: 10.1016/j.bmc.2009.04.056. Epub 2009 May 3. Bioorg Med Chem. 2009. PMID: 19454370 Free PMC article.

4

Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.

Mou J, Fang H, Liu Y, Shang L, Wang Q, Zhang L, Xu W. Mou J, et al. Bioorg Med Chem. 2010 Jan 15;18(2):887-95. doi: 10.1016/j.bmc.2009.11.036. Epub 2009 Nov 22. Bioorg Med Chem. 2010. PMID: 19969464

5

Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.

Luan Y, Wang Q, Liu N, Mou J, Jiao X, Fang H, Li M, Xu W. Luan Y, et al. Among authors: mou j. Anticancer Drugs. 2011 Jan;22(1):99-103. doi: 10.1097/CAD.0b013e32833ab78a. Anticancer Drugs. 2011. PMID: 21048494

6

Design, synthesis, and activity evaluation of a new 5-fluorouracil prodrug containing an Asn-Gly-Arg(NO2)COOCH3 tripeptide.

Luan Y, Jing F, Zhang J, Zou M, Wang X, Jia Y, Liu N, Mou J, Xu W. Luan Y, et al. Among authors: mou j. Protein Pept Lett. 2012 Oct;19(10):1122-31. doi: 10.2174/092986612802762615. Protein Pept Lett. 2012. PMID: 22512656

7

Design, synthesis and activity study of aminopeptidase N targeted 3-amino-2-hydroxy-4-phenyl-butanoic acid derivatives.

Chen LZ, Mou JJ, Xu YY, Fang H, Xu WF. Chen LZ, et al. Among authors: mou jj. Drug Discov Ther. 2011 Apr;5(2):61-5. doi: 10.5582/ddt.2011.v5.2.61. Drug Discov Ther. 2011. PMID: 22466141 Free article.

8

Design, synthesis, and primary activity assays of baicalein derivatives as cyclin-dependent kinase 1 inhibitors.

Mou J, Qiu S, Chen D, Deng Y, Tekleab T. Mou J, et al. Chem Biol Drug Des. 2021 Oct;98(4):639-654. doi: 10.1111/cbdd.13917. Epub 2021 Jul 19. Chem Biol Drug Des. 2021. PMID: 34233076

9

Inhibitors of Cyclin-Dependent Kinase 1/2 for Anticancer Treatment.

Mou J, Chen D, Deng Y. Mou J, et al. Med Chem. 2020;16(3):307-325. doi: 10.2174/1573406415666190626113900. Med Chem. 2020. PMID: 31241436 Review.

10

Design, Synthesis, and Activity Assays of Cyclin-Dependent Kinase 1 Inhibitors With Flavone Scaffolds.

Fu L, Mou J, Deng Y, Ren X, Qiu S. Fu L, et al. Among authors: mou j. Front Chem. 2022 Aug 8;10:940427. doi: 10.3389/fchem.2022.940427. eCollection 2022. Front Chem. 2022. PMID: 36003621 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters